News_Anti-Acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?
By: Louise E Crowley, Andrew Wilson, David R Thickett
We’re delighted to announce that a letter highlighting the clinical need and importance of the TIPAL trial, titled Anti-Acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?, has now been published in the American Journal of Respiratory and Critical Care Medicine.
Congratulations to authors Louise E Crowley, Andrew Wilson and David R Thickett!
Related Articles
From UEA to bestseller list: Ruth Dugdall signs fresh six‑book crime deal
A University of East Anglia graduate has signed a new six-book deal with HQ Harper Collins for an award-winning crime series inspired by her studies in Norwich.
Read more
UEA academic named as National Medical Director in the NHS in England
Prof Frankie Swords from Norwich Medical School has been named as the new National Medical Director for the Department of Health and Social Care and NHS England.
Read more
Norwich Business School enters top 30 in CEO Magazine’s Global MBA Rankings
UEA’s Norwich Business School has been recognised for the first time in CEO Magazine’s Global MBA Rankings, with its MBA offering overall recognised within the “Tier One” Global category and its Executive MBA programme being ranked 28th in the world.
Read more